“There's a huge inertia in the system,” says Alan Shaw, CEO of one such firm, Cranbury, New Jersey–based VaxInnate. That's because existing producers have invested large amounts of time and ...
and VaxInnate. mRNA vaccine heavyweights Pfizer/BioNTech and Moderna, meanwhile, are working on novel shots for flu, although, they are initially focusing their efforts on multivalent seasonal ...
“He's a lab rat, like me,” says Alan Shaw, a prominent member of the Merck development team for Gardasil and now CEO of VaxInnate, a Cranbury, New Jersey–based flu vaccine start-up company.